The prognosis of patients treated with everolimus for advanced ER‐positive, HER2‐negative breast cancer is driven by molecular features
Article in The Journal of Pathology Clinical Research (April 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in The Journal of Pathology Clinical Research (April 2024)
Article in International Journal of Biological Macromolecules (January 2024)
Article in Critical Reviews in Eukaryotic Gene Expression (January 2024)